In New South Wales, a coordinated extracorporeal membrane oxygenation (ECMO) retrieval program has been in operation since 2007. This study describes the characteristics and outcomes of patients transported by this service. We performed a retrospective observational study and included patients who were transported on ECMO to either of two adult tertiary referral hospitals in Sydney, New South Wales, between February 28, 2007 and February 29, 2016. One hundred and sixty-four ECMOfacilitated transports occurred, involving 160 patients. Of these, 118 patients (74%) were treated with veno-venous (VV) ECMO and 42 patients (26%) were treated with veno-arterial ECMO. The mean (standard deviation, SD) age was 40.4 (15.0) years. Seventy-seven transports (47%) occurred within metropolitan Sydney, 52 (32%) were from rural or regional areas within NSW, 17 (10%) were interstate transfers and 18 (11%) were international transfers. Transfers were by road (58%), fixed wing aircraft (27%) or helicopter (15%). No deaths occurred during transport. The median (interquartile range) duration of ECMO treatment was 8.9 (5.2-15.3) days. One hundred and nineteen patients (74%) were successfully weaned from ECMO and 109 (68%) survived to hospital discharge or transfer. In patients treated with VV ECMO, age, sequential organ failure assessment score, pre-existing immunosuppressive disease, pre-existing diabetes, renal failure requiring dialysis and failed prone positioning prior to ECMO were independently associated with increased mortality. ECMO-facilitated patient transport is feasible, safe, and results in acceptable short-term outcomes. The NSW ECMO Retrieval Service provides specialised support to patients with severe respiratory and cardiovascular illness, who may otherwise be too unstable to undergo inter-hospital transfer to access advanced cardiovascular and critical care services.
Extracorporeal membrane oxygenation (ECMO) is an established treatment for adults with severe cardiorespiratory illness. The use of veno-venous (VV) ECMO in severe acute respiratory distress syndrome (ARDS) provides rescue from refractory hypoxia or respiratory acidosis, and facilitates lungprotective ventilation. The 2009 H1N1 Influenza pandemic provided the substrate for a rapid expansion in VV ECMO utilisation 1, 2, 3 despite acknowledged uncertainty around the supporting evidence 4 . Veno-arterial (VA) ECMO is used to support patients with severe circulatory shock. Apart from providing organ perfusion pending myocardial recovery, VA ECMO may provide a bridge to coronary reperfusion therapy, implantation of a mechanical assist device, or heart transplantation.
Successful use of ECMO requires considerable technical expertise, support services and financial outlay. Therefore, ECMO services tend to be concentrated in specialised centres 5, 6 . Observational evidence suggests treatment in a higher-volume centre is associated with better patient outcomes 7 . Medical retrieval on ECMO allows patients with severe cardiorespiratory illness to be transferred to facilities where specialised bridging or destination therapies are available.
Anaesth Intensive Care 2018 | 46: 6 These services might otherwise be inaccessible to such patients, due to physiological instability preventing transport. The ongoing expansion in ECMO services 8 , and improvements in technology particularly regarding pump design 9 , has resulted in an increase in referral centres providing ECMOfacilitated patient transport 10 . Since 2007, two adult tertiary referral hospitals in Sydney, New South Wales (NSW), in cooperation with the Aeromedical and Medical Retrieval Service (AMRS), NSW Ambulance, and the Health Department of NSW, have provided ECMO retrieval and transportation services in the state of NSW. Working within this system, CareFlight (an Australia-based, critical care aeromedical retrieval service) have assisted in international and interstate transfers of patients requiring ECMO. We conducted a retrospective study aiming to describe the characteristics and outcomes of ECMO-facilitated patient transfers, since the inception of the NSW ECMO Retrieval Service. 
Materials and methods

Patient selection
ECMO treatment
Details of the referral process, retrieval team composition, ECMO equipment, cannulation techniques and transport methods have been reported previously 3, [11] [12] [13] . Referrals were by telephone to the on-call intensivist at the study hospitals and included the NSW Ambulance Aeromedical Control Centre. Indications for ECMO referral within the NSW health system were revised in 2014 ( Figure 1 ).
Patients were cannulated percutaneously, using ultrasound guidance, with transoesophageal echocardiography (TOE) to guide cannula positioning. The retrieval team included a cardiac surgeon, cardiothoracic anaesthetist or consultant intensivist, medical perfusion technician, medical retrieval consultant or senior registrar and critical care paramedic. Maquet Rotaflow system and Maquet Cardiohelp system circuits and pumps (Getinge Group, Rastatt, Germany) were used.
Data collection
Patients were identified from the hospitals' ECMO databases. Hospital electronic medical records and paper files were interrogated retrospectively for demographic data, comorbidities, prior treatments, ECMO-related and outcome data. Hospital paper files and the AMRS electronic database (AirMaestro, Avinet, Adelaide, South Australia) were examined for information on patient transfers and transportrelated complications.
Comorbid conditions were defined using the Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcome and Resource Evaluation (CORE) Adult Patient Database (APD) Data Dictionary 14 . Severity of illness scores used the worst available parameters in the 24 hours prior to ECMO commencement, and the first 24 hours following arrival at the receiving centre, to calculate the pre-ECMO Murray score 15 , and the pre-and post-transfer Sequential Organ Failure Assessment (SOFA) score 16 . Hypoxia was defined as peripheral arterial oxygen saturation by pulse oximetry less than 90%, and hypothermia as body temperature less than 36°C. Regarding microbiological diagnoses, only the single most likely causative organism was reported, based on clinical and laboratory findings.
Patients were considered ECMO survivors if they were alive 24 hours after ECMO cessation, and hospital survivors if they were discharged alive from the study hospital or transferred to another facility. Data were entered into separate Research Electronic Data Capture (REDCap) tools hosted at each study hospital, before being collated in a de-identified manner for analysis. REDCap is a secure, web-based application designed to support data capture for research studies 17 .
Statistical analysis
Data are reported as number (percentage) for categorical variables, mean (standard deviation, SD) for normally distributed continuous variables and median (interquartile range, IQR) +/-[range] for non-normally distributed continuous variables.
Comparisons between groups were made using independent t-tests or Kruskal-Wallis test for numeric outcome variables and Pearson's chi-square or Fisher's Exact tests for categorical outcome variables.
Multivariable logistic regression analyses were performed to determine independent risk factors for mortality. Variables screened in univariable analysis included gender, age, weight, body mass index (BMI), presence of chronic comorbidities (respiratory disease, immunosuppressive disease, immunosuppressive treatment, ischaemic heart disease, diabetes mellitus requiring insulin treatment), pregnancy, postpartum state, prior treatments (prone positioning, high frequency oscillatory ventilation (HFOV), neuromuscular blockade, steroids, dialysis), number of days ventilated prior to ECMO commencement, disease severity markers prior to ECMO commencement (pH, lactate, Murray score, PaO 2 /FiO 2 , and SOFA score), diagnosis requiring ECMO, transport geography, transport distance, retrieval dispatch to attendance time and transport time. Clinically important predictors and those with a P-value <0.15 in the univariable analysis were included in multivariable analysis. The statistics produced were the odds ratio (OR), 95% confidence interval (95% CI) of the OR and the overall P-value. These analyses were conducted within the framework of generalised estimating equation to adjust for clustering effects of hospitals.
All statistical tests were two-tailed with the significance level set at 0.05. All statistical analyses were conducted using SAS version 9.4 (SAS Institute Inc, Cary, NC, USA).
Where the pre-sedation Glasgow Coma Scale score was unavailable, this was assumed to be 15. No other assumptions were made regarding missing data; participants with missing values are indicated in the text and tables.
Ethics
The Human Research Ethics Committee of the Sydney Local Health District (RPA Zone) granted ethics approval (LNR/16/ RPAH/292), and all other sites received site-specific approval.
Results
Over the nine-year study period, 160 patients were transported on ECMO to the two study hospitals. A total of 164 transports occurred; four patients were transported initially to RPAH, then to SVH for consideration of heart (n=3) or lung (n=1) transplantation.
Patient characteristics
Ninety-two patients (57.5%) were male. The mean age was 40.4 (SD 15.0) years (range 12.0-81.4 years). The mean weight was 88 (SD 27.0) kg, and the mean BMI was 30.1 (SD 9.7) kg/m 2 . Nine patients (13% of female patients) were pregnant or postpartum (42 days or less following delivery). Other patient characteristics are shown in Table 1 .
Diagnosis requiring ECMO
One hundred and eighteen patients (73.8%) received VV ECMO for respiratory failure. The most common diagnosis requiring VV ECMO retrieval was viral pneumonia, affecting 50 patients (42% of VV ECMO cases). Influenza A was the most common isolated pathogen; the H1N1 strain was confirmed by polymerase chain reaction in 30 patients. Further details on diagnosis and treatments received prior to VV ECMO are listed in Table 2 .
Forty-two patients (26.2%) received VA ECMO for cardiac failure. The most common diagnosis requiring VA ECMO retrieval was cardiogenic shock complicating cardiac surgery, followed by viral myocarditis. Further details on diagnosis and treatments received prior to VA ECMO are listed in Table 3 .
ECMO cannulation and configuration
Of the 164 transports, 130 cases (79.3%) were cannulated for ECMO at the referring centre by the mobile ECMO team.
In the remainder (9 on VV ECMO and 25 on VA ECMO), staff at the referring centre established ECMO and the patients were transported for ongoing care.
Of the 119 VV ECMO transports, 43 cases (36.1%) had a single dual-lumen cannula (Avalon, Maquet, Rastatt, Germany) inserted via the right internal jugular vein. Twentynine (24.4%) underwent bi-femoral cannulation, 20 (16.8%) had a femoral venous drainage cannula with an internal jugular venous return, and 27 (22.7%) had a 'high flow' configuration (bi-femoral and additional jugular venous cannulas).
Of the 45 VA ECMO transports, 42 were on peripheral VA ECMO with the femoral vessels cannulated (except in one case where the return was via a graft to the axillary artery). Thirty-six (88%) of the patients with femoral arterial cannulation had an anterograde perfusion (backflow) cannula inserted immediately on ECMO commencement to maintain distal limb perfusion. In four cases anterograde cannulation could not be performed due to technical difficulties, and in two cases the presence of a backflow cannula could not be determined. In three cases, patients were transported on central VA ECMO, with cannulas that had been surgically implanted prior to referral. They were all post-cardiotomy patients who were transported a distance of less than 10 km within metropolitan Sydney.
Severity of illness
In VV ECMO patients for whom data was available, the median Murray score prior to ECMO commencement was 3.5 (IQR 3.25-3.75) and the median pre-ECMO SOFA score was 8 (IQR 5-10) ( Table 2) . Post-transfer SOFA scores were available for all patients. The median SOFA score in the 24 hours following transfer was 8 (IQR 6-11).
In VA ECMO patients with data available, the median pre-ECMO SOFA score was 10 (IQR 9-13) and the median highest serum lactate prior to ECMO commencement was 6.2 (IQR 4.3-12) mmol/l ( Table 3 ). The median SOFA score in the 24 hours following transfer was 10.5 (IQR 7.7-12.2) and the median highest lactate level was 2.7 (IQR 1.9-4.7) mmol/l.
Transportation data
Of the 164 transfers, 77 (46.9%) occurred within metropolitan Sydney, 52 (31.7%) were from rural or regional areas within NSW, 17 (10.4%) were interstate transfers and 18 (11.0%) were international transfers.
Transfers were by accomplished by road (93 patients, 58.1%), fixed wing aircraft (43 patients, 26.9%) or helicopter (24 patients, 15.0%), missing data for four patients.
The median estimated distance travelled for road transfers was 26 (IQR 16-53) km. The median estimated flight distance was 362 (IQR 225-1,980) km. All international transfers were by fixed wing aircraft from Hôpital Gaston Bourret in Noumea, New Caledonia, a flight distance of 1,980 km from Sydney. Details regarding transfer mode and geography are shown in Table 4 .
Median mission duration (from departure of retrieval team from base, to arrival of the patient at the receiving hospital) was 310 (IQR 211-470) minutes. Median transfer time (from departure of the patient from the referring hospital, to arrival at the receiving hospital) was 110 (IQR 60-199) minutes. 
Transport-related complications
Data on complications during retrieval were available for 151 transfers (92.1%) ( Table 4) . Major complications included power failure of the ECMO pump (n=3) or ventilator (n=1), other ECMO pump malfunction (n=1), circuit air entrainment (n=1), depletion of oxygen supply requiring diversion of the transport aircraft (n=1), pericardial tamponade (n=2), and cardiac rhythm disturbances requiring electrical cardioversion or transcutaneous pacing (n=3). No patients died during transport.
In two cases difficulties were recorded during cannulation for ECMO, requiring a change in cannulation strategy but not resulting in significant harm to the patient. Two patients experienced significant bleeding from the ECMO cannula site during transport. There were no recorded incidents of circuit disconnection, accidental cannula dislodgement or accidental extubation during transfer.
Of the three patients transported on VA ECMO with surgically-inserted central cannulas, one experienced power failure of the ECMO pump, necessitating hand-cranking of the pump. No other transport-related complications were recorded. All three patients experienced significant bleeding from the cannulation site and one patient experienced posttransfer renal failure requiring dialysis, and an ischaemic stroke. All three survived to hospital discharge.
Other transport-related complications included hypotension (n=11, 7.3%), hypoxia (n=17, 11.3%) and hypothermia (n=8, 5.3%).
Outcomes
One hundred and nineteen patients (74%) were successfully weaned from ECMO. One hundred and eleven patients (69%) survived to ICU discharge and 109 (68%) survived to hospital discharge or transfer.
The median duration of ECMO treatment was 9.0 (4. Of the patients who were discharged from the study hospitals, 52 (47.7% of survivors) were transferred to another hospital, usually the hospital of origin. Eighteen (16.5%) were transferred to a rehabilitation facility and 39 (35.8%) were discharged directly home.
The most common cause of death was multi-organ failure, affecting 22 patients (43% of deaths). Twelve patients died from unsupportable haemodynamic instability (five despite treatment with VA ECMO, three following cessation of VA ECMO with a consensus decision not to recommence ECMO support, and four on VV ECMO). In nine patients VV ECMO was ceased due to non-resolving respiratory failure without candidacy for lung transplant. Two patients died from hypoxia following cessation of VV ECMO, with consensus not to recommence. Five deaths were from neurological causes (intracerebral haemorrhage or hypoxic brain injury) and one death was attributed to non-cerebral bleeding.
Seven patients received VV ECMO as a bridge to lung transplantation, six of whom survived to hospital discharge. Six VA ECMO patients received a ventricular assist device, three of whom survived hospital, and one VA ECMO patient underwent heart transplantation and survived to hospital discharge.
Further details regarding outcomes and inpatient complications are shown in Table 5 .
For patients treated with VV ECMO, factors significantly associated with a lower probability of survival to hospital discharge or transfer on univariable analysis were male gender, lower BMI, chronic respiratory disease, preexisting immunosuppressive disease, pre-existing diabetes mellitus, failed prone positioning prior to ECMO, renal failure requiring dialysis prior to ECMO, longer duration of mechanical ventilation prior to ECMO, higher SOFA score prior to ECMO, and diagnosis requiring ECMO (bacterial pneumonia compared with viral pneumonia or other). On multivariable analysis, factors that were significantly 
Discussion
In this retrospective study, we describe the outcomes of an established, coordinated ECMO retrieval service that supports a substantial and increasing number of patients each year. Our data includes the entire cohort of adult patients who have utilised the NSW ECMO Retrieval Service since its inception in 2007. The number of transfers reported is considerable, and will contribute to the increasing body of evidence around ECMO-facilitated patient transport. The incidence of major transport-related complications was low, and survival rates compared favourably with the adult ECMO population overall 8 . Outcome measures were comparable with those reported by other centres providing ECMO retrieval 10 . As expected, our patients were young compared with the Australian adult intensive care population 18 , and relatively free of major comorbidities. Most were treated with VV ECMO for respiratory tract infection. The data presented suggest patients were achieving marginal oxygenation (median PaO 2 /FiO 2 62 mmHg) despite adequate positive end-expiratory pressure, and had airway pressures at or above safe levels, despite tidal volumes within recommended ranges for lung-protective ventilation 19 . Many had received rescue therapies for hypoxic respiratory failure such as neuromuscular blockade, prone positioning and inhaled pulmonary vasodilators. Such patients may benefit from transfer to a specialist centre, however such transports involve considerable risk 5 . Patients on VA ECMO displayed moderate-to-high severity of illness (SOFA score, lactate), carrying a correspondingly high risk of mortality 20, 21 although pre-ECMO severity of illness data was unavailable for over one-third of patients.
The rationale for commencing ECMO prior to transportation is to improve patient safety during transfer. The data presented support this strategy, as major ECMO-related complications during retrieval were uncommon and no deaths occurred during transfer. Cannulation for ECMO by the retrieving team was feasible and resulted in few complications.
Survival to hospital discharge or transfer did not differ significantly between patients treated with VV ECMO compared with VA ECMO, possibly due to the relatively small number of VA ECMO patients included. The use of VA ECMO appears to be increasing worldwide 22 , driven in part by evidence against the use of the intra-aortic balloon pump for treatment of cardiogenic shock 23 . The emergence of adult VA ECMO retrieval highlights some important differences in outcomes and complications between the two patient groups. Our study demonstrated that VV ECMO patients have longer ECMO run times with resulting higher rates of haemolysis and requirement for circuit changes, and a longer duration of ICU admission. In contrast, VA ECMO patients were more likely to suffer ischaemic strokes, and were at considerable risk of limb ischaemia despite the use of retrograde perfusion cannulas. These differences have important implications in both patient-centred outcomes and healthcare resource allocation.
We identified several factors associated with higher mortality risk in patients transported on VV ECMO. Increasing age and a higher pre-ECMO SOFA score were associated with lower survival rates in previous reports on VV ECMO retrieval [24] [25] [26] , while age, renal dysfunction and pre-existing immunosuppression have been incorporated into survival prediction scores for patients treated with VV ECMO [27] [28] [29] [30] . A small proportion of the respiratory failure patients in our study (13%) required dialysis for renal dysfunction prior to ECMO commencement. The increased mortality risk in these patients probably reflects greater overall disease severity. We found that patients who had failed to improve with prone positioning prior to ECMO commencement were less likely to survive to hospital discharge or transfer. This association has not been noted previously and in this retrospective observational study requires cautious interpretation, especially considering a previous randomised controlled trial in ARDS patients described a reduction in mortality achieved by prone positioning 31 . Increased mortality in patients who had undergone prone positioning was most likely related to a greater disease severity in such patients (requiring institution of salvage manoeuvres while awaiting ECMO retrieval or having a more severe form or fibrotic stage of ARDS resulting in failed prone therapy to improve oxygenation before requiring ECMO), a delay in the initiation of ECMO while trialling other treatments, or other undefined mechanisms.
Nearly half the transfers occurred within metropolitan Sydney. This is unsurprising, as around two-thirds of the NSW population resides in the Greater Sydney area 32 . Over 30% of transfers were from rural and regional areas of NSW, with the remainder from interstate or overseas. In NSW, as elsewhere in Australia, healthcare services tend to be concentrated in urban centres 33 . This, along with large geographical distances, can impede healthcare service provision for rural patients. It is feasible for smaller and regional hospitals to successfully establish ECMO programs with the support of larger centres 34 . Nonetheless, a safe and coordinated ECMO retrieval service helps critically ill patients in rural and remote areas to access quaternary-level critical care support.
The study population included 18 patients transferred from an international centre approximately 1,980 km flight distance from Sydney. Of previous studies detailing retrieval distances in patients on ECMO, only a few have described transports of comparable distance 26, [35] [36] [37] [38] [39] . This study has several limitations. First, pre-transfer information was unavailable for some patients. As a result, severity-of-illness data are based on a subset of the study population, and treatments received prior to transfer may have been underestimated. The number of patients treated with VA ECMO was insufficient to identify predictors of mortality in this group.
We did not investigate patients who were referred to the service but were not transferred, or were transported without the use of ECMO. It is unclear how many of the included patients might have survived without ECMO, or whether patients were missed who could have benefited. A robust referral process (for example, using a web-based system) would allow more complete data collection in this regard.
Information on long-term outcomes was not collected. Patients treated for severe respiratory failure often experience significant long-term disability 40, 41 . Future research should focus on outcomes well beyond hospital discharge, especially considering the resource requirement of ECMO services, and the high treatment burden on patients.
Finally, data on transport methods and transport-related complications were missing for a minority of patients. The number of patients with missing data was small, and this would be unlikely to have altered our conclusions. Transportrelated complications may be under-reported in retrospective studies on ECMO retrieval 10, 35 . Prospective data collection might encourage more comprehensive reporting of transportrelated complications.
Conclusion
Retrieval and transportation of patients on ECMO is feasible, results in acceptable outcomes and provides specialised care for patients who otherwise may not have access to advanced cardiorespiratory services and support. A robust referral process including prospective data collection could allow examination of factors predictive of patient outcomes, and guide ongoing service provision.
